In an 85-year-old female who is hemodynamically stable with a hemoglobin of 6.8 g/dL, what is the appropriate management?

Transfuse with 1 unit of packed red blood cells if symptomatic; otherwise, investigate and treat the underlying cause of anemia first

In an 85-year-old hemodynamically stable patient with hemoglobin 6.8 g/dL, you should transfuse 1 unit of RBCs only if the patient has severe anemia-related symptoms (dyspnea, chest pain, altered mental status, or signs of end-organ hypoperfusion). If asymptomatic or minimally symptomatic, prioritize identifying and treating the underlying cause of anemia before transfusing 1, 2, 3.

Immediate Assessment

Check for symptoms of anemia:

• Dyspnea at rest or with minimal exertion
• Chest pain or angina
• Altered mental status or confusion
• Tachycardia despite hemodynamic stability
• Signs of tissue hypoxia (elevated lactate, significant base deficit)

Assess cardiovascular risk:

• History of coronary artery disease, heart failure, or recent acute coronary syndrome
• Active cardiac symptoms
• ECG changes suggesting ischemia

Transfusion Decision Algorithm

If Symptomatic OR High Cardiovascular Risk:

Transfuse 1 unit of packed RBCs 1, 3. The restrictive threshold of 7 g/dL applies to most stable patients, but at 6.8 g/dL with symptoms or cardiac disease, transfusion is justified 2, 3.

• Give single units only in the absence of active bleeding 1
• Recheck hemoglobin after each unit before giving additional transfusions
• Target hemoglobin 7-8 g/dL in stable patients 1, 3
• Consider higher target (8-9 g/dL) if acute coronary syndrome or severe cardiac disease 2, 4

If Asymptomatic AND No Active Cardiac Disease:

Hold transfusion and investigate the cause 3. At hemoglobin 6.8 g/dL without symptoms, the patient has compensated anemia. Transfusion carries risks (volume overload, transfusion reactions, immunomodulation) that may outweigh benefits in an asymptomatic 85-year-old 1, 3.

Workup for Underlying Cause

Order immediately:

• Complete blood count with differential and reticulocyte count
• Iron studies (ferritin, transferrin saturation, serum iron)
• Vitamin B12 and folate levels
• Renal function (creatinine, eGFR)
• Stool for occult blood
• Peripheral blood smear

Consider based on clinical context:

• Hemolysis workup if elevated reticulocytes (LDH, haptoglobin, indirect bilirubin, direct antiglobulin test)
• Bone marrow evaluation if pancytopenia or unexplained anemia
• Gastrointestinal evaluation if occult blood positive or iron deficiency

Treatment of Underlying Cause

For iron deficiency anemia:

• Intravenous iron preferred in elderly: ferric gluconate 250 mg IV daily for up to 7 days 5
• Oral iron if IV not available: ferrous sulfate 324 mg daily 5
• Consider erythropoietin 40,000 IU IV weekly if severe symptomatic anemia with iron deficiency 6, 7

For vitamin deficiencies:

• Vitamin B12 1000 mcg orally daily 5
• Folic acid 5 mg orally daily 5

For chronic kidney disease:

• Erythropoietin-stimulating agents at 30,000-80,000 IU weekly subcutaneously if hemoglobin <10 g/dL and symptomatic 6
• Ensure iron repletion before starting ESA (ferritin >100 ng/mL, TSAT >20%) 6

Critical Caveats for Elderly Patients

Age-specific considerations:

• The 7 g/dL threshold from major trials (TRICC, FOCUS) included elderly patients and showed safety 1, 3, 8
• Liberal transfusion strategies (targeting Hb >9-10 g/dL) do not improve mortality in stable elderly patients and increase transfusion-related complications 1, 3, 8
• However, elderly patients with cardiovascular disease may benefit from slightly higher thresholds (8 g/dL) 2, 4

Avoid routine transfusion above 8 g/dL in hemodynamically stable patients without active cardiac ischemia 2, 3. The AHA/ACC explicitly states that routine transfusion for hemoglobin >8 g/dL in NSTE-ACS patients is not recommended 2.

Monitor for volume overload: Elderly patients have reduced cardiac reserve and are at higher risk for transfusion-associated circulatory overload. Single-unit transfusions with reassessment minimize this risk 1.

When to Transfuse More Aggressively

Transfuse without delay if:

• Active bleeding with hemodynamic instability (hypotension, tachycardia despite fluids) 1
• Hemorrhagic shock 1
• Acute coronary syndrome with ongoing ischemia 2, 4
• Severe symptomatic anemia with evidence of end-organ dysfunction 6, 1

In these scenarios, use massive transfusion protocols if appropriate, but once stabilized, return to restrictive strategy 9.